Amgen Inc.
- BID
320.95
- ASK
321.4
- 156 Units156 Units
- 07/21, 21:59:59 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
25.81%
Market Cap
173.76 Bil.
P/E Ratio
23.01
Dividend Yield
2.91 %
Earnings per Share
12.61 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 321.95 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 09:57:06 PM | |
| DAILY VOLUME (UNITS) | 100 | |
| DAILY HIGH / LOW | 321.95 | 316.75 |
| PREV. DAY'S PRICE | 319.25 | (07/20) |
| CHANGE DAY BEFORE | +2.70 | 0.85 % |
| 52 WEEK HIGH / LOW | 333.25 (03/02) | 230.15 (09/17) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 11.55 | 6.99 | 12.61 | 19.59 | 20.62 |
DIVIDENDS PER SHARE | 7.88 | 8.32 | 8.44 | 8.81 | 9.30 |
DIVIDEND YIELD IN % | 2.96 % | 3.45 % | 2.91 % | - | - |
DIVIDEND GROWTH IN % | 6.80 % | 5.58 % | 1.42 % | - | - |
PRICE - EARNINGS RATIO | 23.07 | 34.48 | 23.01 | 16.34 | 15.53 |
PRICE - BOOK RATIO | 24.74 | 23.81 | 20.37 | - | - |
PRICE - SALES RATIO | 5.53 | 4.24 | 4.83 | - | - |
PRICE - CASH FLOW RATIO | 18.29 | 12.27 | 17.82 | - | - |
Master Data
| WKN | 867900 |
| ISIN | US0311621009 |
| SYMBOL | AMG |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Amgen |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 539.71 Mil. |
| MARKET CAPITALISATION | 173.76 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 0.76 % | 9.88 % | 7.46 % | 13.11 % | 25.81 % | 50.02 % | 52.71 % | 14.41 % |
| HIGH | 328.00 | 328.00 | 328.00 | 333.25 | 333.25 | 333.25 | 333.25 | 333.25 |
| LOW | 310.35 | 291.65 | 274.10 | 274.10 | 230.15 | 208.80 | 173.86 | 271.60 |
Dividende
pro Aktie
Company profile
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Structured products for Amgen Inc.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.